Skip to main content
. 2017 Jul 31;12(7):e0181748. doi: 10.1371/journal.pone.0181748

Fig 4. A schematic representation of distribution of therapeutic peptides and proteins based on disease, function/ mode of activity, route of administration, and pharmacological class.

Fig 4